Figure 2 from INDUCE-3: A Randomized Phase II/III Study of First-line Feladilimab plus Pembrolizumab in Patients with Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
Authors:
- Danny RischinDRDanny Rischin
- Aaron R. HansenAHAaron R. Hansen
- Ezra E.W. CohenECEzra E.W. Cohen
- Makoto TaharaMTMakoto Tahara
- Kevin J. HarringtonKHKevin J. Harrington
- Robert I. HaddadRHRobert I. Haddad
- Lisa LicitraLLLisa Licitra
- Hisham MehannaHMHisham Mehanna
- Robert L. FerrisRFRobert L. Ferris
- Piotr KoralewskiPKPiotr Koralewski
- Konstantin PenkovKPKonstantin Penkov
- Michael SchenkerMSMichael Schenker
Open Access
- 16 March 2026
- other
- Published by American Association for Cancer Research (AACR)